Shield Therapeutics PLC (STX)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

8.50p

Buy

8.70p

arrow-down-0.35p (-3.91%)

Prices updated at 02 Apr 2026, 16:06 BST

Prices minimum 15 mins delay

Prices in GBX

Shield Therapeutics PLC is focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals. It is a specialty pharmaceutical company.

FTSE All-Share

0.59%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

01 Apr 2026

31 Mar 2026

03 Mar 2026

27 Feb 2026

09 Feb 2026

30 Jan 2026

21 Jan 2026

02 Jan 2026

Key dates

	Forecast date
Annual general meeting	May 2026
Final results	Apr 2026
Annual report	Apr 2026
Half yearly results	-

	Previous date
Half yearly results	Aug 2025
Annual general meeting	May 2025
Annual report	Apr 2025
Final results	Apr 2025

Company reports

31 Dec 2022

Annual Report

30 Jun 2025

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.